1Division of Addiction Research and Education, Center for Sports, Exercise and Global Mental Health, Western University of Health Sciences, Pomona, CA, USA
2Division of Nutrigenomics, The Kenneth Blum Neurogenetic and Behavioral Institute, LLC., Austin, TX, USA
3Department of Molecular Biology, Adelson School of Medicine, Ariel University, Ariel, Israel
4Institute of Psychology, ELTE Eötvös Loránd University, Budapest, Hungary
5Department of Psychiatry, University of Vermont, Burlington, VT, USA
6Department of Psychiatry, Wright University Boonshoft School of Medicine, Dayton, OH, USA
7Division of Systems Biology, Victory Nutrition International (VNI), Bonita Springs, FL, USA
8Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX, USA
9Future Biologics, Lawrenceville, GA, USA
10Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biosciences, State University of New York at Buffalo, Buffalo, NY, USA
11Department of Psychology, State University of New York at Buffalo, Buffalo, NY, USA
12Division of Therapeutics and Medical Consequences, Medical Consequences of Drug Abuse and Infections Branch, National Institute on Drug Abuse, NIH, Special Volunteer, Gaithersburg, MD, USA
13Department of Microbiology, Immunology, and Tropical Medicine, The George Washington University School of Medicine, Ross Hall Room 502A, 2300 I Street, Washington, NWDC, USA
14Department of Human Development, California State University at long Beach, Long Beach, CA, USA
15Division of Personalized Medicine, Cross-Cultural Research and Educational Institute, San Clemente, CA, USA
16Awareness Integration Institute, San Clemente, CA, USA
17Ketamine Infusion Clinic of South Florida, Pompano Beach, Fl, USA
18Department of Family Medicine, Jefferson Health Northeast, Philadelphia, PA, USA
19Division Pediatric Neurology, University of Missouri, School of Medicine, Columbia, MO, USA
20Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA
21Karma Doctors and Karma TMS, Palm Springs, CA, USA
22Department of Medicine, University of California, Riverside School of Medicine, Riverside, CA, USA
23Department of Psychiatry, Long School of Medicine, University of Texas Health Science Center, San Antonio, Texas, USA
It is with a saddened heart that we are dedicating this article to the loving memory of our dear departed friend and associate B. William Downs. Bill was well known in the nutritional space worldwide for his major contributions to the health and welfare of millions around the globe. The founder of Victory Nutrition International (VNI) in conjunction with Kim Downs, as well as so many contributions to scientific literature, to those that knew him personally will forever be touched. Bill was a highly spirited human with a never ending love for caring and helping so many individuals. To know Bill is to walk in the face of a music lover playing drums, trained as a martial artist, and riding through the winds of a Beamer driven by an iconic man driven to victory. Our hearts may be saddened but Bills spirit to those that know him will be forever. In this article we discuss and review some potential futuristic concepts and technological advancements in terms of geneospirituality engineering to help prevent relapse and or even protect against an unwanted predisposition to RDS behaviors. Futuristic development may contribute to an attenuation of both DNA antecedents as well as epigenetic reward system insults leading to unwanted substance and non-substance addictive behaviors.
Keywords: Futuristic Thinking; Geneospirituality; Reward Deficiency Syndrome (RDS)
Kenneth Blum., et al. Futuristic Thinking about Engineering “Geneospirituality” to Help Prevent Relapse of Reward Deficiency Syndrome (RDS) Behaviors. EC Psychology and Psychiatry 12.3 (2023): 26-32.
© 2023 Kenneth Blum., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Open Access by ECronicon is
licensed under a Creative Commons Attribution
4.0 International License
Based on a work at www.ecronicon.uk